Get the Stockscreener App
3.375
3.21%
0.105
After Hours:
3.44
0.065
+1.93%
Nyxoah Sa stock is traded at $3.375, with a volume of 47,778.
It is up +3.21% in the last 24 hours and up +7.48% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$3.27
Open:
$3.24
24h Volume:
47,778
Relative Volume:
0.87
Market Cap:
$147.36M
Revenue:
$11.51M
Net Income/Loss:
$-101.84M
P/E Ratio:
-1.2634
EPS:
-2.6714
Net Cash Flow:
$-82.98M
1W Performance:
+11.39%
1M Performance:
+7.48%
6M Performance:
-44.58%
1Y Performance:
-43.56%
1-Day Range:
$3.23
$3.41
1-Week Range:
$2.79
$3.41
52-Week Range:
$2.76
$8.64
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
3.375 | 142.78M | 11.51M | -101.84M | -82.98M | -2.6714 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Baird lowers its price target on Nyxoah SA (NYXH) to $4.62 from $5.87 - MSN
Aug PreEarnings: Is Nyxoah SA forming bullish engulfing patterns2026 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $4.62 - 富途牛牛
Today's Analyst Ratings for Nyxoah (NYXH): Stock Price Target Lo - GuruFocus
Stifel cuts Nyxoah stock price target to $8 on valuation review - Investing.com Canada
Stifel cuts Nyxoah stock price target to $8 on valuation review By Investing.com - Investing.com South Africa
Market Overview: Can Nyxoah SA expand into new marketsPortfolio Gains Report & Consistent Profit Alerts - baoquankhu1.vn
Growth Review: Is now the right time to enter Nyxoah SA2026 Levels & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Breakouts: Will Nyxoah SA benefit from AI trendsWeekly Gains Report & AI Based Buy and Sell Signals - baoquankhu1.vn
NYXH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87 - Insider Monkey
Nyxoah’s Earnings Call Shows Rapid Growth, Rising Risks - TipRanks
NYXH PE Ratio & Valuation, Is NYXH Overvalued - Intellectia AI
Buyout Rumor: Is Nyxoah SA stock undervalued right now2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Exit Recap: Will Nyxoah SA benefit from AI trendsEarnings Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Nyxoah SA (NASDAQ:NYXH) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Cantor Fitzgerald Initiates Nyxoah SA(NYXH.US) With Buy Rating, Announces Target Price $11 - 富途牛牛
[20-F] Nyxoah SA Files Annual Report (Foreign Issuer) | NYXH SEC FilingForm 20-F - stocktitan.net
Bull Run: Can Nyxoah SA ride the EV waveShare Buyback & Accurate Buy Signal Notifications - baoquankhu1.vn
Retail Trends: Is now the right time to enter Nyxoah SAMarket Risk Analysis & Long-Term Safe Return Strategies - baoquankhu1.vn
Breakout Zone: Is Nyxoah SA a speculative investment2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise - MSN
Cantor Fitzgerald Reiterates Overweight Rating for NYXH, Price T - gurufocus.com
Cantor Fitzgerald reiterates Nyxoah stock rating on U.S. launch - Investing.com UK
Nyxoah's (NYXH) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
New Highs: Will Nyxoah SA benefit from rising consumer demandQuarterly Risk Review & Reliable Intraday Trade Plans - baoquankhu1.vn
Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 - MarketBeat
Nyxoah (ENXTBR:NYXH) Losses Of €90 Million Keep Bearish Cash Runway Concerns In Focus - simplywall.st
Nyxoah Discloses Taub Group’s 10.14% Stake After Threshold Crossing - TipRanks
Publication relating to transparency notifications - GlobeNewswire
Stifel Nicolaus Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat
Nyxoah (NYXH) Q4 2025 Earnings Call Transcript - AOL.com
NYXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges By GuruFocus - Investing.com Canada
Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Nyxoah Q4 2025 Earnings Call Transcript - MarketBeat
Nyxoah SA reports results for the quarter ended December 31Earnings Summary - TradingView
NYXH: FDA approval and U.S. launch fueled 122% revenue growth and strong Q4 momentum - TradingView
Nyxoah Q4 Earnings Call Highlights - MarketBeat
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
NYXH: Transformative U.S. launch drove 122% revenue growth and strong Q4 momentum - TradingView
Nyxoah Leverages First Full U.S. Sales Quarter to Power Triple-Digit 2025 Revenue Growth - TipRanks
Nyxoah (NASDAQ: NYXH) doubles 2025 revenue as U.S. launch drives growth but losses deepen - Stock Titan
Nyxoah SA Provides Revenue Guidance for the First Quarter and Second Quarter of 2026 - MarketScreener
Nyxoah SA (NYXH) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - bitget.com
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
What is the long term forecast for Nyxoah SA stockWeekly Trade Summary & AI Driven Stock Movement Reports - baoquankhu1.vn
Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 Result - GuruFocus
Nyxoah SA expected to post a loss of 53 cents a shareEarnings Preview - TradingView
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):